Principia is a pharmaceutical company that develops therapies for immune-mediated diseases. The company was founded in 2011 and has since grown to become a leading developer of therapies for immune-mediated diseases. Principia's pipeline includes therapies for multiple sclerosis, pemphigus, and other autoimmune diseases. The company has a team of experienced professionals who work closely with clients to develop customized solutions that meet their specific needs. Principia is committed to providing high-quality services and has a strong reputation for delivering results.